期刊文献+

张仲景《金匮要略》血痹病证治发挥 被引量:3

Exertion of blood arthralgia in Synopsis of Prescription of the Golden Chamber by ZHANG Zhong-jing
原文传递
导出
摘要 整理研究《金匮要略》血痹病相关文献,结合临证实践,认为血痹病因病机主要是虚、邪、瘀,治则治法是补、温、通。系统性硬化病属于血痹,其核心病机是肺脾肾阳气虚弱、浊邪阻络,温阳化浊通络是其主要治疗方法。临证以黄芪桂枝五物汤为基础加减治疗系统性硬化病疗效显著,具有调节免疫、保护血管和拮抗纤维化的作用。 To collate and study the literature related to blood arthralgia in Synopsis of Prescription of the Golden Chamber,combined with clinical practice,we think that the etiology and pathogenesis of blood arthralgia is mainly deficiency,evil and blood stasis,therapeutic rule is nourishing,warming and dredging.Systemic sclerosis belongs to blood paralysis.Its core pathogenesis is yang deficiency of lung,spleen and kidney,turbid evil obstructing collaterals,and warming yang to remove turbid and dredging collaterals is its main treatment method.In clinical practice,modified Huangqi Guizhi Wuwu Decoction has obvious therapeutic effect in treating systemic sclerosis,which can regulate immunity,protect blood vessels and antagonize fibrosis.
作者 吕芹 卞博 韩立 李凯 陈丽平 卞华 LYU Qin;BIAN Bo;HAN Li;LI Kai;CHEN Li-ping;BIAN Hua(Department of Chinese Medicine,Nanyang Medical College,Nanyang 473061,China;Traditional Chinese Medical College,North China University of Science and Technolony,Tangshan 063210,China;ZHANG Zhong-jing College of Chinese Medicine,Henan Key Laboratory of ZHANG Zhong-jing Formula and Herbs for Immunoregulation,Nanyang Institute of Technology,Nanyang 473004,China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2023年第6期2686-2689,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家自然科学基金项目(No.82074415,No.81774300) 中原科技创新领军人才项目(No.234200510006)。
关键词 金匮要略 血痹病 病因病机 治则治法 系统性硬化病 Synopsis of Prescription of the Golden Chamber Blood arthralgia Etiological factor and pathogenesis Treatment principle and method Systemic sclerosis
  • 相关文献

参考文献10

二级参考文献84

  • 1胡东流,陈达灿,禤国维.系统性硬皮病中医药研究述评[J].中医杂志,2005,46(2):148-149. 被引量:4
  • 2苏立德,颜纪贤.雷公藤多甙治疗系统性硬皮病临床观察[J].中国中西医结合杂志,1994,14(4):234-235. 被引量:21
  • 3李桂,王晓军,李学增,贾凤新,韩聚芳,钮含春.五痹胶囊对系统性硬皮病患者免疫功能的影响[J].北京中医药大学学报,2007,30(5):350-353. 被引量:6
  • 4杨映波 王正国 等.100例我国正常人循环内皮细胞的数量及形态学研究[J].中华医学检验杂志,1993,16(1):36-38.
  • 5Subcomitee of Scleroderma Criteria of the American Rheumatism Association Diagnostic and therapeutic Criteria Committee.Preliminary criteria for the classification of systemic sclerosis(scleroderma)[J].Arthritis Rheum,1980,23(5):581-590.
  • 6Varga JA,Trojanowska M.Fibrosis in systemic sclerosis[J].Rheum Dis Clin North Am,2008,34(1):115-143.
  • 7Shen FY,Ohta A,Yamaguchi M.Inhibition of collagen production by Chinese Herbal Medicine in scleroderma fibroblast cultures[J].Intern Med,1994,33(8):466-471.
  • 8Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.Prelimitary criteria for the classification of systemic sclerosis(scleroderma)[J].Arthritis Rheum,1980,23(5):581-590.
  • 9鄂征.组织培养和分子生物学技术[M]第2版.北京:北京出版社,1997:95-96.
  • 10Leroy EC.Increased collagen synthesis by scleroderma skin fibroblasts in vitro:a possible defect in the regulation or activation of the scleroderma fibroblast[J].J Clin Invest,1974,54(4):880-889.

共引文献58

同被引文献13

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部